Skip to content
โ† Back to browse
BRAIN Publication-derived

Generation of Midbrain-like Organoids (hMLOs) from Human Pluripotent Stem Cells

Source Jo et al. ยท National University of Singapore; National Institute of Mental Health, USA

๐Ÿ‘ค Junghyun Jo, Yixin Xiao, Alfred Xuyang Sun, Huck-Hui Ng โฑ 60 days ๐Ÿ“‹ 3 phases ๐Ÿงซ Human ESC (H1, H9)

Abstract

This protocol describes the generation of midbrain-like organoids (hMLOs) from human pluripotent stem cells that develop functional dopaminergic and neuromelanin-producing neurons. hMLOs are patterned using SHH and FGF8 signaling, embedded in Matrigel, and cultured in differentiation medium to produce mature midbrain tissue with dopaminergic neurons expressing TH, MAP2, and neuromelanin by day 60-146.

Cell source
Human ESC (H1, H9)
Application
Disease modeling; developmental neurobiology

Protocol overview

16 steps across 3 phases

EB Formation and Neuronal Induction Days 0โ€“4
  1. 1 Dissociate hPSCs to single cells
  2. 2 Plate cells in low-adhesion 96-well plates
  3. 3 Add ROCK inhibitor Y27632
  4. 4 Change neuronal induction medium
  5. 5 Add midbrain patterning factors
Matrigel Embedding and Neuroepithelium Expansion Days 7โ€“9
  1. 1 Monitor neuroectodermal bud extrusion
  2. 2 Remove culture medium completely
  3. 3 Embed in reduced growth factor Matrigel
  4. 4 Allow Matrigel to solidify
  5. 5 Culture in tissue growth induction medium
  6. 6 Transfer organoids to ultra-low-attachment plates
Final Differentiation and Maturation Days 9โ€“60+
  1. 1 Culture in final differentiation medium
  2. 2 Use orbital shaker for culture
  3. 3 Include antibiotics to prevent contamination
  4. 4 Change medium every 3 days
  5. 5 Culture until day 60 or beyond

Full SOP

๐Ÿ”ฌ

Create a free account to access this protocol

Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.

Create free account

Already registered? Log in

Attribution

This SOP was authored by Organthis based on the published method in Jo et al.. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.

This wording is awaiting legal review.

Something wrong with this entry? Report an issue with this protocol

Need a commercial licence?
Use this protocol in your therapeutic or diagnostic pipeline.